Cargando…
New clinical score to diagnose nonalcoholic steatohepatitis in obese patients
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is the most frequent disease associated with abnormal liver tests that is characterized by a wide spectrum of liver damage, ranging from simple macro vesicular steatosis to steatohepatitis (NASH), cirrhosis or liver carcinoma. Liver biopsy is the...
Autores principales: | Pulzi, Fernanda BU, Cisternas, Raul, Melo, Murilo R, Ribeiro, Cristiane MF, Malheiros, Carlos A, Salles, João E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055806/ https://www.ncbi.nlm.nih.gov/pubmed/21345221 http://dx.doi.org/10.1186/1758-5996-3-3 |
Ejemplares similares
-
Biochemical Scoring System for diagnosing Nonalcoholic Steatohepatitis
por: Noor-E-Alam, Mohammad, et al.
Publicado: (2016) -
Necroptosis in Nonalcoholic Steatohepatitis
por: Gautheron, Jérémie, et al.
Publicado: (2015) -
Gout in an Obese Patient with Nonalcoholic Steatohepatitis on a Thiazide Diuretic and Association Between Hyperuricemia and Nonalcoholic Steatohepatitis: A Case Report
por: Khan, Zahid, et al.
Publicado: (2023) -
Repurposing drugs to target nonalcoholic steatohepatitis
por: Sookoian, Silvia, et al.
Publicado: (2019) -
New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
por: Mendez-Sanchez, Nahum, et al.
Publicado: (2018)